Skip to main content Back to Top
Advertisement

9/6/2019

Midazolam Injection

Products Affected - Description

    • Midazolam injection, Athenex, 5 mg/mL, 5 mL vial, 10 count, NDC 70860-0601-05
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 10 mL vial, 10 count, NDC 63323-0411-10
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 1 mL fill in 2 mL vial, 25 count, NDC 63323-0412-25
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 10 count, NDC 63323-0412-10
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 5 mL vial, 10 count, NDC 63323-0412-05
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free Luer Lock syringe, 10 count, NDC 00409-2306-62
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free iSecure syringe, 10 count, NDC 00409-2306-12
    • Midazolam injection, Pfizer, 5 mg/mL, 1 mL preservative-free Luer Lock syringe, 10 count, NDC 00409-2307-60

Reason for the Shortage

    • Athenex did not provide a reason for the shortage.
    • Fresenius Kabi has midazolam injection on back order due to increased demand.
    • Hikma has midazolam injection available.
    • Pfizer has midazolam injection on shortage due to manufacturing delays.

Available Products

    • Midazolam injection, Akorn, 5 mg/mL, 10 mL vial, 10 count, NDC 17478-0524-10
    • Midazolam injection, Athenex, 1 mg/mL, 2 mL vial, 25 count, NDC 70860-0600-02
    • Midazolam injection, Athenex, 5 mg/mL, 10 mL vial, 10 count, NDC 70860-0601-10
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0001-20
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 2 mL vial, 25 count, NDC 63323-0411-12
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 5 mL vial, 25 count, NDC 63323-0411-25
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0002-10
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0003-20
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 2 mL vial, 25 count, NDC 63323-0412-02
    • Midazolam injection, Hikma, 1 mg/mL, 10 mL vial, 10 count, NDC 00641-6056-10
    • Midazolam injection, Hikma, 1 mg/mL, 2 mL vial, 25 count, NDC 00641-6057-25
    • Midazolam injection, Hikma, 1 mg/mL, 5 mL vial, 10 count, NDC 00641-6059-10
    • Midazolam injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00641-6061-25
    • Midazolam injection, Hikma, 5 mg/mL, 10 mL vial, 10 count, NDC 00641-6060-10
    • Midazolam injection, Hikma, 5 mg/mL, 2 mL vial, 25 count, NDC 00641-6063-25
    • Midazolam injection, Pfizer, 1 mg/mL, 10 mL vial, 10 count, NDC 00409-2587-05
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free vial, 25 count, NDC 00409-2305-17
    • Midazolam injection, Pfizer, 1 mg/mL, 5 mL preservative-free vial, 10 count, NDC 00409-2305-05
    • Midazolam injection, Pfizer, 5 mg/mL, 1 mL preservative-free vial, 10 count, NDC 00409-2308-01
    • Midazolam injection, Pfizer, 5 mg/mL, 10 mL vial, 10 count, NDC 00409-2596-05
    • Midazolam injection, Pfizer, 5 mg/mL, 2 mL preservative-free vial, 10 count, NDC 00409-2308-02
    • Midazolam injection, Pfizer, 5 mg/mL, 5 mL vial, 10 count, NDC 00409-2596-03

Estimated Resupply Dates

    • Athenex has midazolam 5 mg/mL 5 mL vials on back order and the company cannot estimate a release date.
    • Fresenius Kabi has midazolam 1 mg/mL 10 mL vials and midazolam 5 mg/mL 5 mL vials on back order and the company cannot estimate a release date. There are short-dated midazolam 5 mg/mL 10 mL vials and 1 mL fill in 2 mL vials available with expiration dates of <9 months.
    • Pfizer has midazolam 1 mg/mL 2 mL Carpuject syringes, 1 mg/mL 2 mL iSecure syringes, and 5 mg/mL 1 mL Carpuject syringes on back order and the company estimates a release date of June 2021.

Updated

Updated September 6, 2019 by Rachael Freeman, PharmD, BCPS. Created June 25, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins